Guía fármacoterapeutica de amenaza de parto pretérmino
PDF

Palabras clave

Parto
magnesio
esteroides
progesterona
tocólisis

Cómo citar

Osorio R., A. M., & García C., J. C. (2015). Guía fármacoterapeutica de amenaza de parto pretérmino. Revista Colombiana De Enfermería, 10, 78–89. https://doi.org/10.18270/rce.v10i10.582

Resumen

El parto pretérmino representa un reto terapéutico ya que su tratamiento oportuno disminuye la morbilidad y mortalidad neonatal. Afecta de 5 a 11% de todos los partos en el mundo, entre 9 y 10% en países de bajos ingresos y de 6 a 11,9% en países con altos ingresos. Es el responsable de 70% de las muertes neonatales y 37% de las muertes en infantes así como el causante de 25 a 50% de los casos de falla en el desarrollo neurológico en niños. Por lo anterior, es importante realizar un adecuado tamizaje y tratamiento de las pacientes que se encuentran en riesgo de parto pretérmino. Para ello, se realizó una guía fármacoterapeutica basada en la mejor evidencia para su manejo.

https://doi.org/10.18270/rce.v10i10.582
PDF

Citas

Iams J, Dildy G, Macones G, Silverman N. Prediction and prevention of preterm birth. ACOG. 2012; 120(4): 96 4 -73.

Anotayanonth S, Subhedar NV, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004352. DOI: 10.1002/14651858.CD004352.pub2.

DeFrando E, Lewis D, Odibo A. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol. 2013; 208: 233.e1-6.

McParland P. Obstetric management of moderate and late preterm labour. Seminar in Fetal and Neonatal Medicine. 2012; 17: 138-42.

Facco F, Simhan H. Short ultrasonographic cervical length in women with low-risk obstetric history. ACOG. 2013; 122(4): 858-62.

Romero R, Nicolaides K, Conde-Agudelo A, Tabor A. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012; 206: 124-e1-19.

Ruddock N. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone? Obstet Gynecol Clin N Am. 2011; 38: 235-46.

Iams J. Prevention of preterm parturition. N Enlg J Med. 2014; 370: 254-61. DOI: 10.1056/NEJMcp1103640.

Berghella V. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol. 2012; 376-86.

Ransom C, Murtha A. Progesterone for preterm birth prevention. Obstet Gynecol Clin N Am. 2012; 39: 1-16.

Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD004947. DOI: 10.1002/14651858.CD004947.pub3.

How H, Sibai B. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Therapeutics and Clinical Risk Management. 2009; 5: 55-64.

Mateus J. Clinical management of the short cervix. Obstet Gynecol Clin N Am. 2011; 38: 367-85.

Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T. Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013; 20 8 : 42 . e1-18 .

Berghella V. Universal cervical length screening for prediction and prevention of preterm birth. Obstetrical and Gynecological Survey, CME Review Article. 2012; 67 (10 ) : 6 5 3 - 5 7.

Hassan S, Romero R, Vidyadhari D, Susey S, Baxter J. Vaginal progesterone reduces the rate or preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011; 38: 18-31.

Stock S, Norman J. Preterm and term labour in multiple pregnancies. Seminars in Fetal and Neonatal Medicine. 2010; 15: 336-41.

Duley M, Bennet P. Tocolysis for women in preterm labour. Royal College of Obstetricians and Gynaecologists. Febrero 2011.

Simhan H. Management of preterm labor. ACOG. 2012; 119 (6): 130 8 -17.

Abramovici A, Cantu J, Jenkins S. Tocolytic therapy for acute preterm labour. Obstet Gynecol Clin N Am. 2012; 39: 77-87.

Jacquemyn Y. Prevention of preterm labour: 2011 Update on tocolysis. Journal of Pregnancy. 2011; 1-5.

Haas D, Caldwell D, Kirkpatrick P, McIntosh J, Welton N. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012, 345: 2-16.

Heus R, Willem B, Erwich J. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009; 338: b744.

King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labourCochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD002255. DOI: 10.1002/14651858.CD002255.

Naik Gaunekar N, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour (Review) [Internet]. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004071. DOI: 10.1002/14651858.CD004071.pub2.

Conde A, Romero R, Kusanovic J. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011; 204: 134.e1-2027.

Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004452. DOI: 10.1002/14651858.CD004452.pub2.

Abramovici A, Cantu J, Jenkins S. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin N Am. 2012; 39: 77-87.

Reeves S, Gibbs R, Clark S. Magnesium for fetal neuroprotection. Am J Obstet Gynecol. 2011; 204: 202.e1-4.

Committee Opinion No. 573: Magnesium sulfate use in obstetrics. Obstet Gynecol. 2013: 122(3): 727-8.

Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour (Review) [Internet]. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD001060. DOI: 10.1002/14651858.CD001060.

Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD000940. DOI: 10.1002/14651858.CD000940.pub3.

Papatsonis DNM, Flejandy V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD005938. DOI: 10.1002/14651858.CD005938.pub3.

Dodd JM, Crowther CA, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD003927. DOI: 10.1002/14651858.CD003927.pub3.

Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn J. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. International Journal of Epidemiology. 2013; 39: 122-33

Roberts D. Antenatal corticosteroids to reduce neonatal morbidity and mortality. RCOG Green-top Guideline. 2010; 7: 1-13.

Zephyrin L, Hong K, Wapner R. Gestational age–specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor. Am J Obstet Gynecol. 2013; 209: 330.e1-7.

Rrownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006764. DOI: 10.1002/14651858.CD00676 4.pub3.

Aleman A, Cafferata M, Althabe F, Gibbons L, Ortiz J, Sandoval X, Belizán J. Use of prenatal corticosteroids for preterm birth in tree Latin American countries. International Journal of Gynecology and Obstetrics. 2010; 108: 52-57.

Guías de práctica clínica para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto o puerperio [Internet]. Min. Salud, 2013 [actualizada en abril del 2013; consultado 20 de septiembre de 2014]. http://gpc.minsalud.gov.co/guias/Pages/Gu%C3%ADa-para-complicaciones-en-embarazo.aspx

Hamilton S, Tower C. Management of preterm labour. Obstetrics, Gynaecology and Reproductive Medicine. 2013; 24(3): 114-120.

Bonanno C, Wapner R. Antenatal corticosteroids in the management of preterm birth: are we back where we started? Obstet Gynecol Clin N Am. 2012; 39: 47-63.

Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD003935. DOI: 10.1002/14651858.CD003935.pub3.

Bain E, Middleton P, Crowther CA. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009302. DOI: 10.1002/14651858.CD009302.pub3.

Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004661. DOI: 10.1002/14651858.CD004661.pub3.

Constantine M, Wigner S. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: A Meta-Analysis. Obstet Gynecol. 2009; 114: 354-64.

Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks ‘gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009; 595-609.

Cahill A, Odibo A, Stout M, Grobman W, Macones G, Caughey C. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis. Am J Obstet Gynecol. 2011; 205: 541.e1-7.

Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010; 115(3): 669-71.

Costantine M, Drever N. Antenatal exposure to magnesium sulfate and neuropection in preterm infants. Obstet Gynecol Clin N Am. 2011; 38: 351-66.

Rouse D, Gibbins K. Magnesium sulfate for cerebral palsy prevention. Seminars in perinatology. 2013; 37: 414-16.

Ness A. Prevention of preterm birth based on short cervix: symptomatic women with preterm labor or premature prelabor rupture of membranes. Seminars in Perinatology. 2009; 33: 343-51.

Mercer B. Antibiotics in the management of PROM and preterm labour. Obstet Gynecol Clin N Am. 2012; 39: 65-76.

Lang C, Iams J. Goals and strategies for Prevention of preterm birth: an obstetric perspective. Pediatr Clin N Am. 2009; 56: 537-63.

Sciscione A. Maternal activity restriction and the prevention of preterm birth. Am J Obstet Gynecol. 2010; 202: 232-e1-5.

Sosa C, Althabe F, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003581. DOI: 10.1002/14651858.CD003581.pub2.

Descargas

Los datos de descargas todavía no están disponibles.